Community

HEALTHCARE MEDICAL ANALYTICS MARKET 2025

Eximine Data

HEALTHCARE MEDICAL ANALYTICS MARKET 2025

It has helped in reducing the admission rates in hospitals and has improved the Medicare services. Contact Us:
Email:Sales@Eximine.Com
Phone:8929979895
visit:https://eximine.com/

Eximine Data

From the Author

Eximine Data

Eximine Data

Eximine Data

Eximine Data

Our company is a market research company which provide USA import export data, India Import export data and china Import export data etc.

Which will help you to manage and achieve of something definite,import-export data reports, authenticated analysis, and accurate forecasts.For more information Contact Us:Email:Sales@Eximine.ComPhone:9643566317visit:https://eximine.com/

ESMO and ASCO Abstracts 2020

Ankit Nigam

ESMO Abstracts:CheckMate 067 Results at ESMO 2020Abstract No : Abstract: #1105PIndication : MelanomaIntervention : NivolumabCompany : Bristol-Myers SquibbTechnology : PD-1/PD-L1 inhibitorMixture models adequately captured the survival plateaus in CheckMate 067 and suggested a higher proportion of LTSs with NIVO and NIVO+IPI than with IPI.

These methods may be used in the indirect estimation of auxiliary outcomes, such as time to subsequent treatment and impact of subsequent treatments on LTSs.Read More: https://www.delveinsight.com/esmo-conference-2020/article/checkmate-067-NCT01844505-esmo-2020 CheckMate -577 Results at ESMO 2020Abstract No : Abstract: #LBA9Indication : Esophageal Cancer, Gastroesophageal junction cancerIntervention : NivolumabCompany : Bristol-Myers SquibbTechnology : PD-1/PD-L1 inhibitorAdjuvant nivolumab is the first therapeutic to provide a statistically significant and clinically meaningful improvement in DFS vs placebo and a well-tolerated safety profile in patients with resected EC/GEJC, who have received neoadjuvant CRT.

These results represent the first treatment advance in many years for these patients, potentially establishing adjuvant nivolumab as a new standard of care.Read More: https://www.delveinsight.com/esmo-conference-2020/article/checkmate-577-esmo-2020 KEYNOTE-590 Results at ESMO 2020Abstract No : Abstract #LBA8Indication : Esophageal cancerIntervention : PembrolizumabCompany : Merck & Co.Technology : PD-1/PD-L1 inhibitorPembro + chemo provided superior OS, PFS, and ORR vs chemo, with a manageable safety profile in pts with untreated, advanced esophageal and EGJ cancer.

These data demonstrate that 1L pembro + chemo is a new standard of care in this pt population.Read More: https://www.delveinsight.com/esmo-conference-2020/article/keynote-590-NCT03189719-esmo-2020 ASCO Abstracts:ASCO: Results of KEYNOTE-426Abstract No : 5001Abstract Type : Oral Abstract SessionIndication : Renal Cell CarcinomaIntervention : Pembrolizumab + axitinibCompany : Merck & Co.Technology : Immune Checkpoint Inhibitor (ICI)Pembro + axi continued to demonstrate superior and durable antitumor activity vs sunitinib in pts with first-line aRCC with a 27-mo median follow up; no new safety signals were observed.Read More: https://www.delveinsight.com/asco-conference/article/NCT02853331

How Market Intelligence Enhance Product Development

High Beam Global

If one is unaware of the term than it can simply be defined as the information extracted from the data after analyzing it that provides the company’s trends, competitors help in understanding consumer buying behaviour, helps in making exact decisions based on the information extracted etc. If one business does not show any interest into its market information then it can be clearly be seen as a drawback because it not only takes the business back but drags it back to old-fashioned years resulting in zero growth. The next thing you know, it is falling behind a number of other businesses and its competitors are slashing their way forward and do not seem to stop. It is as simple as that, if you don’t follow up with the trends, you’ll be standing still if not fail and the world will move on. Your product needs development and the rapid changes the market goes through is a tough competition to bear with other than your product’s competitors. New needs, new demands, better results are what customers look for, and to meet such demands, one needs market intelligence to gauge their product development status.